Green tea intake, MTHFR/TYMS genotype and breast cancer risk: The Singapore Chinese Health Study

Carcinogenesis

Volumn 29, Issue 10, 2008, Pages 1967-1972

  Inoue, Maki ^a,b   Robien, Kim ^a,b   Wang, Renwei ^a   Van Den Berg, David J ^c   Koh, Woon Puay ^d   Yu, Mimi C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); EPIGALLOCATECHIN GALLATE; FOLIC ACID; GREEN TEA EXTRACT; THYMIDYLATE SYNTHASE;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; EDUCATION; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; NUTRITIONAL REQUIREMENT; PRIORITY JOURNAL; SINGAPORE; TEA; WOMEN'S HEALTH;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CATECHIN; FEMALE; FOLIC ACID; FOLIC ACID ANTAGONISTS; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; RISK FACTORS; TEA; THYMIDYLATE SYNTHASE;

EID: 53449102887     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn177     Document Type: Article

References (50)

1. Yang,C.S. et al. (2006) Possible mechanisms of the cancer-preventive activities of green tea. Mol. Nutr. Food Res., 50, 170-175.
2. Mukhtar,H. et al. (2000) Tea polyphenols: Prevention of cancer and optimizing health. Am. J. Clin. Nutr., 71, 1698S-1702S.; discussion 1703S-1704S.
3. Lambert,J.D. et al. (2005) Inhibition of carcinogenesis by polyphenols: Evidence from laboratory investigations. Am. J. Clin. Nutr., 81, 284S-291S.
4. Smart,E.C. et al. (2006) Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci., 79 2329-2336.
5. Mukhtar,H. et al. (1999) Green tea in chemoprevention of cancer. Toxicol. Sci., 52, 111-117.
6. Wu,A.H. et al. (2003) Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer., 106, 574-579.
7. Suzuki,Y. et al. (2004) Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br. J. Cancer. 90, 1361-1363.
8. Nagano,J. et al. (2001) A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control, 12, 501-508.
9. Sun,C.L. et al. (2006) Green tea, black tea and breast cancer risk: A meta-analysis of epidemiological studies. Carcinogenesis, 27, 1310-1315.
10. Nakachi,K. et al. (1998) Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res., 89, 254-261.
11. Inoue,M. et al. (2001) Regular consumption of green tea and the risk of breast cancer recurrence: Follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett., 167, 175-182.
12. Seely,D. et al. (2005) The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: A systematic review and meta-analysis. Integr. Cancer Ther., 4, 144-155.
13. Wu,A.H. et al. (2003) Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res., 63, 7526-7529.
14. Yuan,J.M. et al. (2005) Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis, 26, 1389-1394.
15. Yamada,K. et al. (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc. Natl Acad. Sci. USA, 98, 14853-14858.
16. Weisberg,I. et al. (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab., 64, 169-172.
17. Frosst,P. et al. (1995) A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet., 10, 111-113.
18. de Bree,A. et al. (2003) Effect of the methylenetethydrofolate reductase 677C->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am. J. Clin. Nutr., 77, 687-693.
19. Lievers,K.J. et al. (2001) A second common variant in the methylenetetra-hydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J. Mol. Med., 79, 522-528.
20. Ulrich,C.M. et al. (2000) Searching expressed sequence tag databases: Discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol. Biomarkers Prev., 9, 1381-1385.
21. Mandola,M.V. et al. (2004) A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics, 14, 319-327.
22. Hankin,J.H. et al. (2001) Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr. Cancer, 39, 187-195.
23. Koh,W.P. et al. (2003) Angiotensin 1-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res., 63, 573-578.
24. Parkin,D.M. et al. (2002) Cancer Incidence in Five Continents IARC Scientific Publications, Lyon.
25. Rastogi,T. et al. (2008) Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int. J. Epidemiol, 37, 147-160.
26. Yuan,J.M. et al. (2007) Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology, 46, 749-758.
27. Breslow,N.E. et al. (1980) Statistical methods in cancer research. Volume I - the analysis of case-control studies. IARC Sci. Publ., 32, 5-338.
28. Yuan,J.M. et al. (1988) Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res., 48, 1949-1953.
29. Stegmann,K. et al. (1999) Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects(NTD). Am. J. Med. Genet. 87, 23-29.
30. Navarro-Peran,E. et al. (2005) The antifolate activity of tea catechins. Cancer Res., 65, 2059-2064.
31. Zheng,W. et al. (1996) Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am. J. Epidemiol. 144, 175-182.
32. Goldbohm,R.A. et al. (1996) Consumption of black tea and cancer risk: A prospective cohort study. J. Natl Cancer Inst., 88, 93-100.
33. Michels,K.B. et al. (2002) Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women. Ann. Epidemiol., 12, 21-26.
34. Adebamowo,C.A. et al. (2005) Dietary flavonols and flavonol-rich foods intake and the risk of breast cancer. Int. J. Cancer, 114 628-633.
35. Zintzaras,E. (2006) Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: A meta-analysis. Clin. Genet., 69, 327-336.
36. Stevens,V.L. et al. (2007) Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol. Biomarkers Prev., 16, 1140-1147.
37. Lewis,S.J. et al. (2006) Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J. Natl Cancer Inst., 98, 1607-1622.
38. Martin,Y.N. et al. (2006) Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 15, 2322-2324.
39. Justenhoven,C. et al. (2005) One-carbon metabolism and breast cancer risk: No association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol. Biomarkers Prev., 14, 3015-3018.
40. Le Marchand,L. et al. (2004) MTHFR polymorphisms, diet, HRT, and breast cancer risk: The multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev., 13, 2071-2077.
41. Xu,X. et al. (2007) Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 28, 1504-1509.
42. Lissowska,J. et al. (2007) Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: A population-based case-control study and meta-analyses. Int. J. Cancer, 120, 2696-2703.
43. Chen,J. et al. (2005) One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res., 65, 1606-1614.
44. Langsenlehner,U. et al. (2003) The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res. Treat., 81, 169-172.
45. Campbell,I.G. et al. (2002) Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res. 4, R14.
46. Macis,D. et al. (2007) Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: A nested-case-control study and a pooled meta-analysis. Breast Cancer Res. Treat., 106, 263-271.
47. Chou,Y.C. et al. (2006) Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: A case-control study in Taiwan. Carcinogenesis, 27, 2295-2300.
48. Friso,S. et al. (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl Acad. Sci. USA, 99, 5606-5611.
49. Shrubsole,M.J. et al. (2004) MTHFR polymorphisms, dietary folate intake, and breast cancer risk: Results from the Shanghai Breast Cancer Study. Cancer Epidemiol. Biomarkers Prev., 13, 190-196.
50. Ervin,R.B. et al. (2004) Dietary intake of selected vitamins for the United States population: 1999-2000. Adv. Data, 339, 1-4.